complex based on X-ray crystallography analysis is presented. Remarkably, the CUE1 domain, which resembles a canonical CUE domain, recognizes 2 clusters of exposed hydrophobic residues on KAP1, but these are presented in the context of a coiled-coil domain, not in a structure resembling ubiquitin.
Introduction
CUE domains are ubiquitin-binding domains (UBDs) that interact with ubiquitin by occupying the hydrophobic pocket centred on the highly conserved ubiquitin I44 residue [1] [2] [3] . As is typical of most UBD-ubiquitin interactions, CUE-ubiquitin interactions are relatively weak, reflecting a comparatively small interaction surface of only ~400Å 2 4-7 . CUE domains have two main conserved sequence elements -a methionine-phenylalanine-proline (MFP) motif and a di-leucine (LL) repeat, both of which are essential for ubiquitin binding 4, 5, 8 . With the rare exception of ubiquitinhomology domains (UbHs), ubiquitin remains the only known ligand of CUE domains 1, 9 . As UBDs are essential in detecting the ubiquitylation status of their partner proteins, they often play a crucial role in mediating the regulation of biological processes by ubiquitylation. Thus, mutation of the UBD of a protein to perturb its interaction with ubiquitin is often a reasonable starting point for interrogating the biological function of that protein.
SMARCAD1 is a candidate for investigation in this manner, as it has a pair of CUE domains and biological functions that merit further characterization at a mechanistic level. SMARCAD1 is a chromatin remodeler, a member of the SWI2/SNF2-like family of enzymes that couple the energy released from ATP hydrolysis to repositioning, ejecting, or restructuring nucleosomes 10 . SMARCAD1 has homologues spanning considerable evolutionary distance -its homologues are Fun30 in budding yeast, Fft1, Fft2 and Fft3 in fission yeast, and Etl1 or HEL1 in mouse 11, 12 . By virtue of its split-ATPase domain, SMARCAD1 is most closely related to the Swr1-like group of remodelers, including INO80 and SWR1
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. Specific biochemical activity has not, to date, been demonstrated for human SMARCAD1.
However, the INO80 and SWR1 remodelers primarily facilitate histone dimer exchange, and the SMARCAD1 homologue Fun30 similarly preferentially mediates histone exchange over nucleosome sliding [13] [14] [15] . It seems likely that SMARCAD1 will play a comparable role in mediating histone exchange in vertebrates.
Functionally, SMARCAD1 has been implicated in facilitating homologous recombination by promoting end-resection, and in maintaining constitutive heterochromatin through DNA replication 16, 17 . Its S. pombe homologue, Fft3, has been reported to modulate nucleosome exchange -both promoting it, in association with elongating RNA polymerase II to relieve the nucleosomal barrier to transcription, and suppressing it, to facilitate heterochromatin maintenance 18, 19 . In a Xenopus egg extract system, SMARCAD1 promotes Msh2-dependent mismatch repair on a chromatin template 20 . Collectively, these observations link SMARCAD1 to the regulation of various processes in the context of the chromatin environment [16] [17] [18] [19] [20] [21] [22] [23] [24] .
KAP1 (also known as TRIM28 and TIF1β) is the major interaction partner of SMARCAD1, with the two proteins forming a tight complex 16, 25 . KAP1 is ubiquitously expressed, and is implicated in transcription repression, heterochromatin formation, and in DNA repair, amongst other functions [26] [27] [28] [29] [30] . KAP1, in common with other TRIM proteins, has a distinctive RBCC domain -a composite of RING, tandem B-box and coiled-coil domains. Additional features of KAP1 are a central HP1-box and a Cterminal PHD-bromodomain 26, 27 .
Recent structural work has demonstrated that the RBCC domain of the homologous TRIM25 protein forms an elongated structure, dominated by its coiledcoil domain homo-dimerizing in an antiparallel manner 31 . Specifically, each coiled-coil subunit forms a hairpin, with a short arm consisting of a C-terminal linker region that folds back onto a long arm, comprised of the coiled-coil domain proper. The coiledcoil has a distinctive palindromic arrangement (i.e. 7-7-7-7-11-11-11-11-7-7-7-7) of heptad (denoted '7') and hendecad (denoted '11') repeats 31 . The centrally located hendecad repeats form an underwound R-handed helix that is infiltrated by the linker helices of the short arm, resulting in a central four-helical bundle. The N-terminal RING and B-boxes are located at the apices of the coiled-coil, whereas C-terminal domains (e.g. the PHD-bromodomain in KAP1) presumably protrude from either side of the centre of the coiled-coil 31 . Other TRIM proteins share this overall structural configuration [31] [32] [33] . This architectural organization enables TRIM proteins to assemble protein domains in a modular fashion; hence, TRIM proteins should excel as scaffolds for recruiting specific cellular machinery to target locations. It is also conceivable that the considerable exposed surface created by TRIM coiled-coil dimerization might represent yet another interaction surface.
Given the functional significance of the SMARCAD1 protein, and the undetermined significance of its CUE domains, we focused on the SMARCAD1 CUE domains for further investigation.
Results

SMARCAD1 and KAP1 Interact Directly in a Ubiquitylation-Independent Manner
The SMARCAD1 protein contains a pair of tandem CUE domains of largely unknown function ( Figure 1A ). We generated human cell lines, depleted of endogenous SMARCAD1 by shRNA knockdown, which were then reconstituted with shRNAresistant cDNA encoding either FLAG-tagged wild type SMARCAD1 or SMARCAD1
with point mutations in the CUE domains ("CUE1mt,2mt"), under the control of a doxycycline-inducible promoter ( Figure 1B ). The CUE1mt,2mt protein should be compromised in its ubiquitin-binding ability, as each of its CUE domains possesses four alanine substitutions targeting the conserved, hydrophobic MFP and di-leucine motifs that are integral to the ubiquitin interaction surface 2 . As expected, KAP1 coimmunoprecipitated with wild type SMARCAD1 ( Figure 1C , lane 8). Strikingly, however, point mutation of the tandem CUE domains abrogated the interaction (lane 9). As CUE domains are ubiquitin-binding domains, SMARCAD1-KAP1 interaction might involve ubiquitylated KAP1. We explored whether cells possess a pool of ubiquitylated KAP1 by isolating ubiquitylated proteins from 293T human cell extract using MultiDsk affinity purification 34 , and then examining KAP1 ubiquitylation by Western blot analysis. Surprisingly, however, no ubiquitylated KAP1 was detected by this approach (data not shown).
We previously found that the CUE domain of the yeast Def1 protein recognizes the ubiquitin-homology (UbH) domain of Elongin A (Ela1) 9 . Thus, the possibility that KAP1 similarly interacts directly with SMARCAD1 in a ubiquitylationindependent manner was considered. Exploiting the inability of prokaryotes to ubiquitylate proteins, recombinant SMARCAD1 and KAP1 were purified following expression in E. coli ( Figure S1A and D) , and then tested for their ability to interact in vitro. After mixing, KAP1 indeed co-immunoprecipitated with SMARCAD1 ( Figure 1D , lane 7), indicating that these proteins interact directly, in a ubiquitylation-independent fashion. Remarkably, the purified SMARCAD1 CUE1mt,2mt protein showed little binding to KAP1 (lane 10), recapitulating the observation in mammalian cells.
Similarly, SMARCAD1 protein with point-mutations only in the first CUE domain ("CUE1mt,2") was significantly compromised in its ability to bind KAP1 (lane 8), while point mutation of only the second CUE domain ("CUE1,2mt") did not perceptibility affect the interaction (lane 9). Collectively, these data indicate that the SMARCAD1-KAP1 interaction is a direct protein-protein interaction that is mediated via the first CUE domain of SMARCAD1, and that the tandem CUE domains of SMARCAD1 are not functionally redundant for this function.
We next investigated whether a stable SMARCAD1-KAP1 complex could be reconstituted in vitro. A simple strategy of sequential FLAG-and HA-affinity purification from a mixture of FLAG-tagged SMARCAD1 and HA-tagged KAP1
proteins was adopted ( Figure S2A ). It was, indeed, possible to reconstitute a SMARCAD1-KAP1 complex containing stoichiometric quantities of each of the partner proteins ( Figure S2B , lane 8). Furthermore, the reconstituted SMARCAD1-KAP1 complex behaved as expected for a stable protein complex on gel filtration chromatography ( Figure S2C ). We conclude that SNARCAD1 and KAP1 not only interact, but form a highly stable protein complex.
The RBCC Domain of KAP1 and the First CUE Domain of SMARCAD1 are
Necessary and Sufficient for the SMARCAD1-KAP1 Interaction
Close inspection of the domain architecture of KAP1 did not offer any indications about the region of the protein that is recognized by the first CUE domain of SMARCAD1. Consequently, limited tryptic digestion was used to identify KAP1 fragments that reflect the tertiary structure of the protein -three KAP1 fragments were relatively resistant to tryptic digestion ( Figure 2A , lane 5). To map these fragments, the sequences of their N-termini were determined by Edman degradation, while their mass was measured to a high level of accuracy by intact molecular weight mass spectrometry. Interpreted in light of the knowledge that trypsin cleaves after lysine or arginine residues, the largest KAP1 fragment ("Fragment 1", S33-K434, 45kDa) was found to span the RBCC domain of KAP1 ( Figure 2B ). Further cleavage yields a second fragment, which encompasses the second B-box and the coiled-coil domain ("Fragment 2", S200/D202-K434, 27kDa). The final fragment ("Fragment 3", L592-P835, 26kDa) spans the C-terminal PHD-bromodomain ( Figure 2B ).
The three trypsin-resistant fragments were expressed in E. coli as GST fusion proteins. Crude bacterial protein extracts containing these GST fusion proteins, or full-length GST-KAP1 as a control, were then incubated with beads immobilised with a SMARCAD1 CUE1,2 fragment (S95-N347), encompassing both of the CUE domains ( Figure 2C ). The SMARCAD1 CUE1,2 fragment strongly enriched both fulllength KAP1 and the S33-K434 RBCC fragment ( Figure 2D , lanes 7 and 8).
Crucially, this interaction depended on the integrity of the first CUE domain of SMARCAD1: point mutation in this domain completely abrogated binding (lanes 12 and 13). It is worth noting that KAP1 D202-K434 was not readily expressed in E. coli, exhibited poor solubility, and frequently precipitated during purification (data not shown). Thus, the apparent inability of the D202-K434 fragment to bind to the SMARCAD1 CUE1,2 fragment (lanes 9 and 14) might potentially simply reflect its tendency to aggregate and low abundance in the extracts.
To further confirm that KAP1 S33-K434 is responsible for the interaction with SMARCAD1, it was purified and tested in a binding assay similar to that described To further investigate the unprecedented possibility of a CUE domain binding a ligand structurally distinct from ubiquitin, we crystallized the KAP1 RBCC domain (residues 53 to 434) in complex with the SMARCAD1 CUE1,2 fragment (residues 94-347). The structure was determined to 5.5Å resolution by single-wavelength anomalous diffraction, using the intrinsic anomalous signal of the zinc ions (i.e. 4 per KAP1 subunit). Despite the relatively low resolution, the experimental phases were of excellent quality ( Figure 3A ) and were significantly improved by solvent flattening algorithms due to the extremely high solvent content of 92%, which is amongst the highest in the PDB archive. The high solvent content reflects the unusual packing arrangement within the crystal, which has a unit cell of 300Å diameter in the form of a large proteinaceous cage with internal voids ( Figure S4A ). Despite numerous permutations of constructs and crystallization conditions, this was the highest resolution achieved. It was, nevertheless, possible to build a full atomic model of the complex, aided by the availability of templates for individual domains, and the ability to determine the sequence register unequivocally at sites of zinc ion coordination and at breaks in secondary structural elements.
As previously observed with other TRIM family members [31] [32] [33] , the asymmetric unit features a single, elongated dimer ( Figure 3B ). The dimer interface is extensive (5300Å 2 ) and is formed primarily by the antiparallel association of the coiled-coil domains, with additional contributions from the RING and second B-box domains.
The central coiled-coil domain is comprised of a long arm and a short arm that are Electron densities corresponding to the first B-box domain could not be seen ( Figure   3A ), nor could the zinc ions bound by this domain be located in anomalous difference maps, suggesting that this domain does not associate with the central core; this interpretation was also supported by limited proteolysis experiments (data not shown).
Similarly, electron density was only observed for a single CUE domain ( Figure 3A ), which we interpreted to be SMARCAD1 CUE1, based on our data indicating its importance to the SMARCAD1-KAP1 interaction. The SMARCAD1
CUE1 domain is formed of 3 helices and demonstrates considerable structural similarity to the CUE domains of the yeast CUE2p and human gp78 proteins 4, 7 (RMSD of around 1.8Å) ( Figure 3C ). One distinguishing feature of the SMARCAD1 CUE1 domain, however, is an extended α 1 helix that extends for an additional 3 turns ( Figure 3C ), though the function of this extension is unclear. Reassuringly, our model of the SMARCAD1 CUE1 is largely comparable to the structure of the isolated domain determined independently by NMR 35 .
Our structural model shows a single SMARCAD1 CUE1 domain bound to each end of the KAP1 coiled-coil dimer. The majority of contacts (i.e. approximately 700Å 2 of a total interface area of around 850Å 2 ) are between CUE1 and an exposed surface at the C-terminal end of the long arm of the coiled-coil domain of one KAP1
subunit, but the interface also involves the RING domain of the other KAP1 subunit of the homodimer ( Figure 3B and D). The interaction surface on the KAP1 coiled-coil domain is comprised principally of exposed hydrophobic residues, supplemented by a few polar residues at the peripheries. Correspondingly, hydrophobic residues appear to be the primary constituents of the SMARCAD1 CUE1 interaction surface; among these residues are the conserved FP motif (i.e. F169 and P170) and part of the conserved di-leucine motif (i.e. L196) ( Figure 3D ).
Taken together, the structural model suggests that though the SMARCAD1 CUE1 and KAP1 RBCC domains appear prima facie to largely resemble other CUE and TRIM RBCC domains respectively, they nevertheless succeed in associating directly and specifically with each other, mainly on the basis of exposed hydrophobic residues. Remarkably, it also provides clear evidence that the SMARCAD1 CUE1 binds a KAP1 domain that bears no structural resemblance to ubiquitin. It is notable, however, that the surface employed by SMARCAD1 CUE1 to interact with KAP1 RBCC is comparable to that employed by other CUE (e.g.
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CUE2p-1) and UBA domains (e.g. Dsk2 UBA) for canonical binding to mono-ubiquitin and ubiquitin-like (UbL) domains ( Figure 4C ). This interface is formed from the exposed surfaces of the As the surface on SMARCAD1 CUE1 that would typically be involved in canonical ubiquitin binding is already deployed and optimized for interacting with the KAP1 RBCC, it is unlikely that SMARCAD1 CUE1 can bind simultaneously to KAP1 RBCC and ubiquitin. While non-canonical UBD-ubiquitin/UbL interactions have been reported 36, 37 , this is unlikely to be applicable to SMARCAD1 CUE1 as the dissociation constant for it binding mono-ubiquitin has been measured by NMR titration experiments to be roughly 1.8 mM 35 , too weak to represent a biologically meaningful interaction. Together, these data supports a model for the SMARCAD1 CUE1
domain uniquely mediating a distinct interaction with KAP1 rather than functioning as a generic UBD.
Unfortunately, we were unable to determine a motif unique to SMARCAD1
CUE1 to help predict other CUE (or other UBDs) that might similarly recognize a ligand structurally distinct from ubiquitin (data not shown). This is in large part because conserved residues, such as the integral MFP motif, are still present in SMARCAD1 CUE1 and in fact retain important roles in the SMARCAD1 CUE1-KAP1 RBCC interaction; additional residues, for instance T164 ( Figure 6A ), have simply been co-opted to customize the exposed α 1-α3 helix surface for KAP1 RBCC binding. It is thus apparent that sequence conservation is insufficient evidence to implicate a given UBD in canonical ubiquitin binding, and the possibility of it mediating non-canonical interactions with non-ubiquitin(-like) ligands has to be tested empirically.
The KAP1 Interaction Surface is Not Conserved Amongst TRIM Proteins
The structures of TRIM5α, TRIM20 and TRIM25 have previously been reported [31] [32] [33] , and were compared to that of KAP1 ( Figure 5A ). Although all the TRIM proteins have a similar, central anti-parallel coiled-coil, it is notable that each coiledcoil has a unique geometry, and that the degree to which each helix deviates off its axis varies between the TRIM proteins. Importantly, in contrast to KAP1, none of the other TRIM proteins has the pattern of two clusters of exposed hydrophobic residues on their coiled-coil domains in the region of the coiled-coil where SMARCAD1 CUE1
interacts with KAP1, suggesting that this is not a conserved architectural feature of TRIM proteins ( Figure 5A ). We conclude that, compared to other proteins of the TRIM family, KAP1 possesses a unique pattern of exposed hydrophobic residues, which form an interaction surface to bind the CUE1 domain of SMARCAD1.
Rittinger and colleagues have recently elucidated the crystal structure of the coiled-coil domain of TRIM25 in complex with either the TRIM25 PRYSPRY domain or the influenza A non-structural protein 1 (NS1) 38 . Notably, they observe that both the TRIM25 PRYSPRY domain and NS1 protein bind to exterior surfaces of the coiled-coil, albeit on opposite sides of the coil. Comparison of these structures to our SMARCAD1 CUE1-KAP1 RBCC model reveals that all of these interactions localize to a similar region towards the end of the anti-parallel coiled-coil. In fact, it is striking that the region on the TRIM25 coiled-coil surface recognized by the PRYSPRY domain is nearly equivalent to that utilized on the KAP1 coiled-coil domain for SMARCAD1 CUE1 binding ( Figure 5B ). Nevertheless, the contacts underpinning these distinct interactions are different -the TRIM25 coiled-coil-PRYSPRY interaction being dependent a pair of conserved tyrosine residues (i.e. Y463 and Y476) that project into the coiled-coil 38 , in contrast to SMARCAD1 CUE1, which forms hydrophobic interactions with two clusters of exposed hydrophobic residues on the KAP1 coiled-coil ( Figure 5B ). While it has not possible to identify sequence features or structural elements that enable prediction of interactions involving the coiled-coil domains of TRIM proteins from this limited data, it is intriguing to speculate that a general feature of TRIM proteins is that the region towards the end of their anti-parallel coiled-coil acts as an interaction surface for varying partner proteins.
Validation of the Structural Model by Mutagenesis
We sought to validate our structural model by mutation of key residues that might be expected to abrogate the SMARCAD1-KAP1 interaction. Residues identified by the structural model to potentially be important for the interaction were mutated to alanine in the previously described SMARCAD1 CUE1,2 and KAP1 RBCC fragments ( Figure 2) . Additionally, the 4 residues that were co-targeted in the CUE1mt,2 mutant were also individually mutated. The purified CUE1,2 mutants were tested in binding assays. Notably, SMARCAD1 T164A, L168A or F169A mutation abrogated the ability of the CUE1,2 fragment to bind KAP1 RBCC to the same extent as the quadruple CUE1 mutation ( Figure 6A , lanes 5, 8, 9 and 17). Our structural model indicates that SMARCAD1 T164 forms contacts with M378, on which the first hydrophobic cluster of the KAP1 interaction surface is centred, while SMARCAD1 L168 and F169 contact KAP1 I338, a component of the second hydrophobic cluster (Figure 3D , right; Figure   4A ).
We next investigated whether mutations targeting these KAP1 residues would also affect SMARCAD1 binding, as predicted by the structural model. Gratifyingly, Nevertheless, these results together provide strong empirical support for the notion that the mechanism by which the SMARCAD1 CUE1 domain binds to KAP1 is by recognition of two clusters of exposed hydrophobic residues on the coiled-coil domain.
The CUE1mt,2 fragment used in Figures 1 and 2 is a composite of the F169A, P170A, L195A and L196A mutations, and was designed to target both the conserved MFP and the di-leucine repeat motifs. Strikingly, the inability of the CUE1mt,2 to bind KAP1 appears to be almost exclusively due to the F169A mutation, as neither P170A, L195A nor L196A point mutation individually had a noticeable effect on the ability of the CUE1,2 fragment to bind KAP1 RBCC ( Figure   6A , compare lanes 10, 14 and 15 with lane 9 and 17). This helps further support the hypothesis that the SMARCAD1 CUE1-KAP1 RBCC interaction is fundamentally different from canonical CUE-ubiquitin interactions, as the proline of the MFP motif and the second leucine of the di-leucine repeat form important hydrophobic contacts with ubiquitin. Indeed, L47A mutation of the CUE2p-1 domain (analogous to the L196A mutation of SMARCAD1 CUE1) completely disrupts ubiquitin binding in vitro 4 .
In addition to the crucial role played by the two exposed hydrophobic clusters in one KAP1 subunit's coiled-coil domain for binding to a SMARCAD1 CUE1 domain, our model also identified potentially important interactions between the same CUE1 domain and the RING domain of the other KAP1 subunit of the KAP1 homodimer.
These interactions involve P170 and Q171 of SMARCAD1 CUE1, and residues C120, K121 and Q122 of the KAP1 RING domain (see Figure 3D , right). However, substitution of P170 or Q171 for alanine had no noticeable effect on the ability of the target an interaction at the periphery of the interface and outside of the hydrophobic clusters, also had no discernible effect on the interaction ( Figure 6B, lane 14) . Thus, it appears that these electrostatic interactions are indeed peripheral, in that they may, at least individually, only offer minor contributions to the interaction.
Collectively, the mutagenesis experiments empirically validate the structural model and support the conclusion that the mechanism underpinning the SMARCAD1-KAP1 interaction relies principally upon the SMARCAD1 CUE1 domain recognising two exposed hydrophobic clusters on the KAP1 coiled-coil, with minor contributions from contacts between residues at the periphery of the interaction surface. The first hydrophobic cluster is centred upon KAP1 M378, while the second is crucially reliant upon I338. Notably, this mechanism of interaction is fundamentally different from the filled hydrophobic pocket employed in canonical CUE-ubiquitin interactions. Although the presence of exposed hydrophobic clusters at the end of the coiled-coil domain does not appear to be a shared architectural feature of other TRIM proteins, this may yet transpire to be a conserved mechanism by which other CUE domains form direct protein-protein interactions with their partner proteins. One inevitable question raised by these observations is the mechanism by which a CUE interaction can be rendered significantly more stable than classical ubiquitin-UBD binding. Although our structural model has not conclusively addressed this issue, it is possible that the avidity of the SMARCAD1 CUE1-KAP1 RBCC interaction is enhanced by the requirement for the SMARCAD1 CUE1 to recognize two, rather than a single, exposed hydrophobic cluster. This is supported by the observation that mutagenesis compromising the integrity of either hydrophobic cluster alone was sufficient to abrogate the interaction. Another consideration is that the modest dissociation constants for ubiquitin-based interactions are typically measured for the interaction between a UBD and mono-(or di-)ubiquitin in isolation.
Discussion
CUE Domains Mediate Protein Interactions
Hence, these reported dissociation constants may give the impression of weaker interactions than in reality, since a weak UBD-ubiqutin interaction, in the presence of additional specificity domains, could result in an overall stable protein-protein interaction between a UBD-containing protein and its ubiquitylated partner 3, 39 . Yet, the SMARCAD1-KAP1 interaction is distinctive in being very stable, but apparently dependent only on the CUE1-RBCC interaction, a phenomenon also observed in human cells. Free ubiquitin cannot out-compete recombinant KAP1 RBCC for binding to SMARCAD1 CUE1, and once formed, the SMARCAD1-KAP1 complex withstands dilution or washing with high salt buffers. Overall, our findings help support a model of CUE domains, and presumably UBDs as a whole, potentially fulfilling a general role in mediating protein-protein interactions, besides functioning as ubiquitin-binding domains. Further work will obviously be required to confirm the generalizability of this hypothesis.
Regulation of SMARCAD1
SMARCAD1 is a poorly characterized, putative chromatin remodeler that is conserved from budding yeast to humans, whose main interaction partner in human cells is KAP1 16, 25 
The KAP1 RBCC Domain as an Interaction Interface
Our structural model of the SMARCAD1 CUE1-KAP1 RBCC complex confirms that the KAP1 RBCC adopts a structural architecture comparable to other TRIM proteins.
It also complements the previously reported structure of the C-terminal KAP1 PHDbromodomains, meaning that the 3D structure of nearly the entire KAP1 protein has been elucidated, though it will be crucial to determine the organization of the various domains in relation to one another 29 . TRIM proteins adopt an elongated appearance, dominated by a central coiled-coil, and accessorized not only by N-terminal RING and B-box domains at the apices, but also by additional C-terminal protein domains protruding from the centre of the central helix [31] [32] [33] . This modular assembly of multiple proteins domains render TRIM proteins particularly adept as scaffold proteins, recruiting the desired molecular machinery to specific cellular or genomic locations, which with reference to KAP1, would presumably be in recruiting epigenetic and DNA repair machinery variously to sites of DNA damage or heterochromatin.
Notably, we show that the SMARCAD1-KAP1 interaction does not occur via a discrete protein domain of KAP1. Rather, the SMARCAD1 CUE1 recognizes an exposed surface, with a particular pattern of hydrophobic residues and orientated in a specific geometry, which is created by homo-dimerization of the KAP1 coiled-coil domains. Intriguingly, Rittinger and colleagues recently reported that a comparable exposed surface of the TRIM25 coiled-coil domain mediates interaction with the TRIM25 PRYSPRY domain, while influenza A NS1 can bind to the opposite side of the TRIM25 coiled-coil domain, though simultaneous interaction of both factors cannot be accommodated due to distortion of the linker connecting the H2 and H3
helices by NS1 binding 38 . It is unclear why the ends of the coiled-coil domains appear to be hotspots for interactions, though it is possible that the close proximity of the flexible linker between the H2 and H3 helices in that region of the coiled-coil allows unique interaction surfaces to be created without disrupting the intermolecular packing of the H1 helices. Nevertheless, protein-protein interactions involving the exterior surface of coiled-coil domains may represent a general feature of TRIM proteins, and it would be intriguing to investigate which other TRIM proteins adopt a similar mode of interaction with their partner proteins. However, we note that it is difficult to predict a priori whether a certain partner protein will interact with a specific TRIM protein in this manner, given the considerable exposed areas of each coiledcoil, and the idiosyncrasies in the precise geometry of the helix of each TRIM protein.
In spite of these caveats, our findings tentatively support a model of TRIM proteins functioning as an interaction interface by two mechanisms -first, through discrete protein domains that autonomously mediate protein-protein interactions, and second, by supporting interactions that involve exposed surfaces created by oligomerization of the coiled-coil domain.
Methods
Plasmids
Human SMARCAD1 and KAP1 cDNA was cloned into a pET28a-SUMO vector, a kind gift from Peter Cherepanov (Crick Institute), for bacterial expression. cDNA was also cloned into the pcDNA4/TO vector (Thermo Fisher Scientific) for use with T-Rex inducible mammalian expression system. Epitope tags, point mutations and truncations were introduced by standard PCR methods. Full length KAP1 and various KAP1 mutants were cloned into the GST expression vector, pGEX6P1 (GE Healthcare). SMARCAD1 CUE1,2 and KAP1 RBCC mutants used to validate our structure were generated by GenScript (Piscataway, USA).
Generation of Stable Cell Lines
293 T-Rex cells were depleted of endogenous SMARCAD1 by GIPZ lentiviral shRNA (Dharmacon) knockdown, before being rescued with doxycycline-inducible expression of exogenous, shRNA-resistant, FLAG-tagged SMARCAD1 or SMARCAD1 CUE1mt,2mt, using the T-Rex system (ThermoFisher Scientific).
Individual colonies were isolated. Doxycycline titration identified concentrations that resulted in exogenous SMARCAD1 being expressed at approximately endogenous levels.
Preparation of Cell Extracts & Protein Detection
Soluble bacterial extracts were prepared in GST-L-Zn buffer (20mM Tris, 100mM SMARCAD1 was nickel-affinity purified with a 5mL HisTrap HP column (GE Healthcare), then dialysed overnight at 4°C against P-100 buffer (10mM sodium phosphate, 100mM NaCl, 10%(v/v) glycerol, 5mM β -ME; pH7.50 at 4°C) in the presence of 100μg of recombinant Ulp1 (a SUMO protease). Subsequent chromatographic steps were a 5mL HiTrap Heparin HP column (GE Healthcare), ProSwift WCX-1S (ThermoFisher Scientific) for SMARCAD1 CUE1,2mt and SMARCAD1 CUE1mt,2mt, and ProSwift SAX-1S (ThermoFisher Scientific). The final fractions were concentrated using a Microcon spin concentrator (Millipore) with a 50K
MWCO and exchanged into P-100 buffer.
SMARCAD1 CUE1,2 and CUE1 fragments were first affinity purified using 3mL of Ni-NTA agarose (Qiagen). The SUMO tag was cleaved by recombinant Ulp1 (140μg) during dialysis against Q-100 buffer (10mM Tris, 100mM NaCl, 10%(v/v) glycerol, 5mM β -ME; pH7.90 at 4°C), and depleted by reloading the sample over the 3mL of Ni-NTA resin and collecting the unbound flow-through. If required, these purifications were followed by ion exchange chromatography on a 1mL Mono Q 5/50 GL column (GE Healthcare). The samples were concentrated with Amicon Ultra-4 10K MWCO spin concentrators (Millipore).
As KAP1 and the KAP1 RBCC contain zinc-finger domains, they were expressed whilst cultured in LB supplemented with 50μM ZnSO 4 or ZnCl 2 , and all buffers used in the purification protocol contained 50μM ZnSO 4 or ZnCl 2 . KAP1 was purified using a 5mL HisTrap HP column, dialysed against P-100 buffer in the presence of recombinant Ulp1 (100μg), then loaded onto a 5mL HiTrap Heparin HP column. The eluate was concentrated to a volume of approximately 4mL using an Amicon Ultra-15 30K MWCO spin concentrator, before being loaded onto a 120mL
HiPrep 16/60 Sephacryl S-400 HR gel filtration column (GE Healthcare). The sample was re-concentrated using a spin concentrator; the final buffer was GF-150Zn buffer (10mM Tris, 150mM NaCl, 50μM ZnSO 4 , 2mM DTT; pH7.90 at 4°C).
KAP1 RBCC (S33-K434) was purified using 3mL of Ni-NTA agarose, cleaved with recombinant Ulp1 (140μg) during dialysis against Q-100 buffer, and depleted of its SUMO tag as described above. This was followed by chromatography on a 1mL
Mono Q 5/50 GL column, and peak fractions dialyzed against Q-100 buffer.
The KAP1 RBCC-SMARCAD1 CUE1,2 complex was purified on a 5mL
HisTrap HP column, dialyzed against Q-100 buffer, during which the SUMO tag was cleaved by recombinant Ulp1 (140μg), then loaded onto an 8mL Mono Q HR 10/10 column (GE Healthcare). Peak fractions were concentrated to approximately 4mL using an Amicon Ultra-15 30K MWCO spin concentrator, before further purification by gel filtration chromatography using a 120mL HiLoad 16/60 Superdex 200 column (GE Healthcare), the peak of which was re-concentrated using a spin concentrator. β -ME. The complex was then reconstituted by sequential affinity purification with anti-HA (3F10) affinity matrix (Roche) and anti-FLAG M2 affinity gel (Sigma). Bound proteins were eluted respectively with HA (1mg/mL) and FLAG peptide (500μg/mL, Peptide Chemistry core facility, Francis Crick Institute), prepared in P-100 buffer.
Reconstitution of SMARCAD1-KAP1
Analytical gel filtration chromatography was performed using a 4×300mm
MAbPac SEC-1 column (ThermoFisher Scientific). 375ng of protein was loaded per run, and eluted isocratically in P-200 GF buffer (10mM sodium phosphate, 200mM
NaCl, 2mM DTT; pH7.50 at 4°C).
Crystallization, Structure Determination & Refinement
For crystallization an N-terminally SUMO-tagged KAP1 G53-K434 fragment was overexpressed in E.coli BL21(DE3)-R3-pRARE2 cells. Cells were grown at 37°C in TB medium supplemented with 50μg/mL kanamycin until an optical density of 2-3, then induced with 0.3 mM IPTG and incubated overnight at 18°C. Purification was as described above for KAP1 S33-K434, with the exception of the final purification step of size exclusion chromatography using a HiLoad 16/60 Superdex S200 column, where a buffer containing 50mM Hepes pH7.5, 500mM NaCl, 5% glycerol and 0.5mM Tris (2-carboxyethyl) phosphine (TCEP) was used instead. KAP1 G53-K434 was concentrated to 10mg/ml using a Millipore 30,000 MWCO centrifugal concentrator and mixed with SMARCAD CUE1,2 (purified as described above) in a A SAD dataset extending to 5.5Å was collected at Diamond Light Source beamline i03 and the data were processed using DIALS
41
. The structure was solved using Phenix autosol 42 using the intrinsic anomalous signal of the zinc ions, and the initial phases were improved substantially by solvent flattening. Model building was performed using either existing crystal structures of fragments or template derived models, which were directly fitted in to the experimentally phased maps based on zinc ions (i.e. RING and B-box domains) or recognizable secondary structure elements (i.e. coiled-coil and CUE1 domain). Side chain positions were chosen from preferred rotamers that minimized clashes with neighbouring atoms and the structure was refined using Phenix refine 43 , using both NCS and reference model restraints, and a single B-factor per residue. A summary of the data collection and refinement statistics is shown in Table 1 .
Refined structures were visualized and analysed using UCSF Chimera
44
. For comparative analysis, atomic coordinates were obtained from the PDB using accessions 1OTR (ubiquitin-CUE2-1 complex) 4 , 1WR1 (Dsk2 UBA-ubiquitin complex) 45 , 2BWE (Dsk2 UBA-Dsk2 UBL complex) 46 , 4TN3 (TRIM5α) 32 , 4CG4
(TRIM20) 33 , 4LTB (TRIM25) 31 , 6FLN (TRIM25 coiled-coil-TRIM25 PRYSPRY complex) 38 and 5NT2 (TRIM25 coiled-coil-NS1 complex) 38 .
SMARCAD1-KAP1 Binding Assays
For the binding assay with purified full-length SMARCAD1 and KAP1, 7μg of each was mixed together in a 280μL binding reaction containing SK binding buffer (10mM β -ME) three times before the beads were eluted with 30μL of 2X SDS-PAGE loading buffer by heating the samples to 100°C for 5 minutes.
The binding assays involving purified fragments of SMARCAD1 (i.e. CUE1,2 and CUE1) and KAP1 (i.e. RBCC) were performed similarly, with the following slight adjustments: 9.6μg of each protein was used in a 240μL binding reaction incubated for 1 hour at 4°C, and immunoprecipitated with 15μL of anti-FLAG M2 affinity gel for 3 hours at 4°C before elution as described above. The effect of ubiquitin on the SMARCAD1-KAP1 interaction was investigated by adding purified recombinant, monomeric ubiquitin (Boston Biochem) to the binding reaction.
The affinity resin of immobilized SMARCAD1 CUE1,2 fragment was prepared by saturating the binding capacity of the M2 resin with three-fold as much purified FLAG-tagged protein (approximately 12.2nmol protein/mL resin), incubating the beads at 4°C overnight, before washing off unbound protein. To 20μL of CUE1,2-coupled resin, E. coli extracts containing GST-tagged KAP1 fragments (2.5mg of total protein per reaction) were added and incubated at 4°C for 3 hours. The beads were washed thrice in SK-200 buffer thrice, before being eluted as above.
Limited Tryptic Proteolysis
Limited tryptic digestion was performed in trypsin buffer (20mM Tris pH7.40, 50mM
NaCl, 1mM CaCl 2 , 2mM DTT) using 1/1000 (w/w) the amount of trypsin as purified protein. The reactions were stopped by addition of a protease inhibitor cocktail. For
Edman degradation, digested samples were resolved by SDS-PAGE, transferred onto an Amersham Hybond P 0.45 PVDF membrane (GE Healthcare), and stained with Ponceau S (Sigma), following which, selected bands were excised. Edman degradation (5 cycles each) was performed by AltaBioscience.
For intact molecular weight mass spectrometry, the digested samples were first incubated with 50mM DTT to remove β -ME adducts (from the purification buffers). Tryptic peptides were removed using an Ultrafree-CL centrifugal filter unit with a 5K MWCO (Millipore). LC/MS grade formic acid (Fisher Scientific) was added for a concentration of at least 0.2% (v/v) and pH.
Data Accessibility
Atomic coordinates and structure factors for the X-ray structure of the KAP1 RBCC-SMARCAD1 CUE1,2 complex have been deposited in the PDB with accession 6H3A.
Other data and constructs used in this study are available from the corresponding author upon reasonable request. A. Limited tryptic proteolysis of purified recombinant KAP1 yields three main fragments that are relatively resistant to trypsin.
B.
The three trypsin-resistant KAP1 fragments mapped by Edman degradation and intact molecular weight mass spectrometry. The domains encompassed by each of these fragments are depicted.
C. Schematic representation of SMARCAD1 fragments spanning either both CUE domains ("CUE1,2") or only the first CUE domain ("CUE1") that were expressed and purified. E. FLAG-tagged SMARCAD1 CUE1,2 fragments used to validate the structural model.
F.
As in E, but KAP1 RBCC fragments. A. The unit cell is a proteinaceous cage with internal voids, explaining the extremely high solvent content of the crystal. 
